Handbook_Volume III

127 blood/article/97/10/2962/89681/Comparison-of-outcomes-of-unrelated-bone-marrow 20. Kanter J, Liem RI, Bernaudin F, Bola os-Meade J, Fitzhugh CD, Hankins JS, et al. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. Blood Adv [Internet]. 2021 Sep 9 [cited 2022 Jun 19];5(18):3668. Available from: /pmc/articles/PMC8945587/ 21. Peters C, Matthes-Martin S, Poetschger U, Schrappe M, Schrauder A, Von Stackelberg A, et al. Stem-cell transplantation in children with acute lymphoblastic leukemia:A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial. J Clin Oncol. 2015 Mar 20;33(11):1265–74 22. Ringden O, Remberger M, Gustafsson B, Moretti G, Mattsson J, Winiarski J, et al. The outcome of allogeneic hematopoietic stem cell transplantation for inherited diseases is influenced by HLA match, year of transplantation, and immunized female donor. Transplantation [Internet]. 2019 Jun 1 [cited 2022 Jun 19];103(6):1247–52. Available from: https://journals.lww.com/transplantjournal/Fulltext/2019/06000/The_Outcome_of_Allogeneic_ Hematopoietic_Stem_Cell.34.aspx 23. Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, et al. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. Blood [Internet]. 2014 Jul 31 [cited 2022 Jun 19];124(5):822–6. Available from: https://ashpublications.org/ blood/article/124/5/822/116627/HLA-haploidentical-stem-cell-transplantation-after 24. Bertaina A, Zecca M, Buldini B, Sacchi N, Algeri M, Saglio F, et al. Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood [Internet]. 2018 Dec 13 [cited 2022 Jun 19];132(24):2594–607. Available from: https://pubmed.ncbi.nlm.nih.gov/30348653/ 25. Saglio F, Berger M, Spadea M, Pessolano R, Carraro F, Barone M, et al. Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia. Bone Marrow Transplant [Internet]. 2021 Mar 1 [cited 2022 Jun 19];56(3):586–95. Available from: https://pubmed.ncbi.nlm.nih.gov/32968215/ 26. Stern M, Ruggeri L, Mancusi A, Bernardo ME, De Angelis C, Bucher C, et al. Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood [Internet]. 2008 Oct 1 [cited 2022 Jun 19];112(7):2990–5. Available from: https://ashpublications.org/blood/article/112/7/2990/24774/ Survival-after-T-cell-depleted-haploidentical-stem 27. Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A. Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood [Internet]. 2011 Jan 20 [cited 2022 Jun 19];117(3):764–71. Available from: https://ashpublications.org/blood/article/117/3/764/125534/Killer-Ig-like-receptor-mediated-control-of 28. Oevermann L, Michaelis SU, Mezger M, Lang P, Toporski J, Bertaina A, et al. KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood [Internet]. 2014 Oct 23 [cited 2022 Jun 19];124(17):2744–7. Available from: https://ashpublications.org/ blood/article/124/17/2744/33255/KIR-B-haplotype-donors-confera-reduced-risk-for 29. Lehrnbecher T, Averbuch D, Castagnola E, Cesaro S, Ammann RA, Garcia-Vidal C, et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol [Internet]. 2021 Jun 1 [cited 2022 Jun 19];22(6):e270–80. Available from: https://pubmed.ncbi.nlm. nih.gov/33811814/ 30. Castagnola E, Bagnasco F, Menoni S, Muraca M, Prete A, Belotti T, et al. Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant [Internet]. 2018 Sep 1 [cited 2022 Jun 19];53(9):1193–7. Available from: https://pubmed. ncbi.nlm.nih.gov/29563591/ 31. Cesaro S, Tridello G, Castagnola E, Calore E, Carraro F, Mariotti I, et al. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients. Eur J Haematol [Internet]. 2017 Sep 1 [cited 2022 Jun 19];99(3):240–8. Available from: https:// onlinelibrary.wiley.com/doi/full/10.1111/ejh.12910 32. Groll AH, Pana D, Lanternier F, Mesini A, Ammann RA, Averbuch D, et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol [Internet]. 2021 Jun 1 [cited 2022 Jun 19];22(6):e254–69. Available from: https://pubmed.ncbi.nlm.nih.gov/33811813/ 33. Corbacioglu S, Jabbour EJ, Mohty M. Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/ Sinusoidal Obstruction Syndrome. Biol Blood Marrow Transplant [Internet]. 2019 Jul 1 [cited 2022 Jun 19];25(7):1271–80. Available from: https://pubmed.ncbi.nlm.nih.gov/30797942/ 34. Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant [Internet]. 2018 Feb 1 [cited 2022 Jun 19];53(2):138–45. Available from: https://pubmed.ncbi.nlm.nih.gov/28759025/ 35. Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, et al. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant [Internet]. 2020 Jun 1 [cited 2022 Jun 19];55(6):1126–36. Available from: https://pubmed.ncbi.nlm.nih.gov/32029909/ 36. Packman W, Weber S, Wallace J, Bugescu N. Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review. Bone Marrow Transplant [Internet]. 2010 Jul [cited 2022 Jun 21];45(7):1134–46. Available from: https://pubmed. ncbi.nlm.nih.gov/20383219/ 37. Baker KS, Bresters D, Sande JE. The burden of cure: longterm side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am [Internet]. 2010 Feb [cited 2022 Jun 19];57(1):323–42. Available from: https://pubmed. ncbi.nlm.nih.gov/20307723/ 38. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, et al. Long-term health-related outcomes in survivors 1. Aspetti Generali